Evidence map›Paper›PMID 37857693›Full record

ArticleNature communications2023

Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.

Sandor Spisak, Viktoria Tisza, Pier Vitale Nuzzo, Ji-Heui Seo, Balint Pataki, Dezso Ribli, Zsofia Sztupinszki, Connor Bell, Mersedeh Rohanizadegan, David R Stillman and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Sandor SpisakDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-7834-4642
Viktoria TiszaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Pier Vitale NuzzoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-5618-8079
Ji-Heui SeoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Balint PatakiDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.ORCID http://orcid.org/0000-0002-7974-5712
Dezso RibliDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.ORCID http://orcid.org/0000-0002-2709-206X
Zsofia SztupinszkiComputational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.
Connor BellDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-2148-2972
Mersedeh RohanizadeganDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-5636-7317
David R StillmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Sarah Abou AlaiwiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-7073-3432
Alan H BartelsDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Marton PappInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.ORCID http://orcid.org/0000-0003-4975-253X
Anamay ShettyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Forough AbbasiWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Xianzhi LinWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0001-9802-9896
Kate LawrensonWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-6469-2515
Simon A GaytherDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0001-7937-5443
Mark PomerantzDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Sylvan BacaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Norbert SolymosiDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.ORCID http://orcid.org/0000-0003-1783-2041
Istvan CsabaiDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary.ORCID http://orcid.org/0000-0001-9232-9898
Zoltan SzallasiComputational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0001-5395-7509
Alexander GusevDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-7980-4620
Matthew L FreedmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-0151-1238

Funding

Physician Scientist Training in Cancer ResearchT32CA009172 · NCI · DANA-FARBER CANCER INSTITUTE · PI Jennifer R Brown, James A. DeCaprio · 1985 to 2026
$17.1M
NCI NIH HHS T32 CA009172
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37857693
PMCPMC10587226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.